The continuing shortage of controlled stimulants, such as Adderall and Ritalin, has created a frustrating “yo-yo scenario” of providers and patients trying to find the right medications when they’re needed for attention deficit hyperactivity disorder (ADHD). The crisis has no clear end in sight.
Patient Care Pharmaceutical Sciences
The latest nicotine trend touted on social media could be the stealthiest and most dangerous yet. TikTok influencers are targeting teenagers with promises that nicotine pouches, a discreet way of getting a nicotine jolt, can do everything from enhancing masculinity to providing a powerful “buzz.”
With a growing number of studies suggesting that ashwagandha does fulfill its marketed claims of reducing stress and anxiety and improving sleep, the herb’s popularity has boomed, gaining the attention of consumers and healthcare providers alike.
Research Drug Development Quantum
Although a search for “quantum” in the popular media turns up mostly references to a revived TV series (“Quantum Leap”) and a recent superhero film (“Quantumania”), in the science world, the actual technology is creating quite the buzz.
Research Press Releases Cancer Pharmacy
A new peer-reviewed study in the American Journal of Human Genetics highlights the work of the biobank at the Colorado Center for Personalized Medicine (CCPM), a world-class site for precision medicine in research and clinical care created in partnership with the University of Colorado Anschutz Medical Campus and UCHealth.
Research Community Public Health
Record funding, a growing workforce and new collaborations were among the highlights of the Dec. 12 annual State of Research address. Presented live over Zoom, Vice Chancellor for Research Thomas Flaig, MD, shared the 2023 research landscape and the many ways his office is partnering with investigators to advance scientific discovery.
Research Innovation CU Anschutz 360 Podcast Cell and Gene Therapy
In the best of cases, taking a new drug from lab to clinic takes about six to eight years, a vast improvement over the roughly 20-year timeline decades ago. Drug development pace and efficiency are leaping even farther ahead, courtesy of quantum computing, artificial intelligence algorithms and 3D tissue printers, especially at the University of Colorado Anschutz Medical Campus.
Research Patient Care Education Community
Chancellor Don Elliman delivered his annual State of the Campus Address on Nov. 16 to nearly 750 community members online and in-person, highlighting the campus’s strong stance at the forefront of innovation in health and medicine.
Press Releases Mental Health Pharmacy Pharmaceutical Sciences
Hundreds of clinics may be using false and misleading statements in online advertising campaigns by offering off-label and unapproved ketamine to treat a variety of mental health and pain conditions, according to researchers at the University of Colorado Anschutz Medical Campusand Johns Hopkins University.
When a headache calls and the only ibuprofen in the house is a bottle that is expired, is it worth a trip out to replace it?
Press Releases Pharmacy Pharmaceutical Sciences
The burning of sugarcane and rice husks may be releasing a toxicant causing a mysterious kidney disease in agricultural workers, according to a paper out today in the American Journal of Kidney Diseases.
Research Press Releases Pharmacy
A new study may offer a strategy that mitigates negative side effects associated with intravenous injection of nanoparticles commonly used in medicine.
Is kratom a welcome respite for those with chronic pain? Or is it a different style of opioid that can be addictive?
Research Pharmaceutical Sciences
Phenylephrine is the most popular oral decongestant in the country, but further scrutiny by scientists has found that the ingredient is actually no better than a placebo.
Patient Care Community Opioid Research
The nation’s fentanyl overdose crisis appeared within a few steps of Eduardo Ornelas at a recent music festival in Colorado.
Clinical Research Child & Adolescent Research Pharmacy
Researchers at the University of Colorado Anschutz Medical Campus have helped confirm the dosing, safety and effectiveness of a drug formulation designed for treating children with human immunodeficiency virus (HIV).
Research Innovation Patient Care
The University of Colorado Anschutz Medical Campus this week announced the Anschutz Acceleration Initiative, a program to advance cutting-edge healthcare innovations that are poised to reach patients within the next three to five years.
Community Mental Health Addiction
It’s no secret that Coloradans are struggling with substance use and mental health issues.
Patient Care Public Health Pharmaceutical Sciences
The recent Food and Drug Administration approval of the nasal spray Narcan is good news for music festival attendees hoping to carry the medication in case they witness an opioid overdose.
Researcher and scientist Qiong Zhou, MS, finds herself, quite literally, at the center of drug discovery and innovation.
As professor and founding director of the Center for Drug Discovery (CDD) at the Skaggs School of Pharmacy and Pharmaceutical Sciences, Daniel LaBarbera, PhD, is leading the forefront of drug innovation.
Community Diversity Equity Diversity and Inclusion
The national Society for the Advancement of Chicanos/Hispanics and Native Americans in Science (SACNAS) strives to increase diversity in the scientific workforce. This year, the organization found the highest embodiment of its ideals at the University of Colorado Anschutz Medical Campus.
Fentanyl’s growth from its original design as an effective surgical pain management tool to a leading cause of overdose death and concern has happened quickly – with severe consequences.
The University of Colorado Anschutz Medical Campus hosted its second annual Research Awards ceremony on Oct. 25. More than 125 people gathered to recognize the contributions of their fellow colleagues with cheers and standing ovations. With eight different award categories and over a dozen individual awardees, the event highlighted the significant depth, strength and teamwork of the CU Anschutz research community.
Research Diversity Pharmaceutical Sciences
Growing up in a family of machinists, Carlos Catalano was fascinated by the inner workings of devices. Wrist watches, especially, weren’t safe around the family home in Southern California.
A new study published in today’s issue of the Journal of the American Medical Association (JAMA) analyzes the benefits and harms of prior authorization (PA) policies for Medicare and the impact these policies have on patients and clinicians.
A new study suggests that therapeutic interventions to treat neurodevelopmental disorders may be more effective if done during the early stages of brain development.
Research Education Faculty Awards
Joseph Gal, PhD, was trained in chemistry, is fluent in French, and spent most of his career in medical science research. More recently, he focused his activities on the history of science and more specifically on the renowned French scientist Louis Pasteur.
Is melatonin safe for children? Can you take it in addition to other medications? Luke E. Orth, PharmD, BCPPS, an assistant professor in the Department of Clinical Pharmacy at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences and a clinical pharmacy specialist at Children’s Hospital Colorado, addresses the factors to consider when taking melatonin to help you fall asleep.
Research Pharmaceutical Sciences
Could oxidative stress, a condition known to cause inflammation and cellular breakdown, impact the trajectory of Down syndrome cell development?
Research Press Releases Pharmacy
Since June, the number of COVID-19 infections started rising again, as the most transmissible omicron variant started picking up delta variant mutations leading to new subvariants BA.4/BA.5 and Deltacron variants. Out of all the five known variants of concern, which have been shown to evade therapeutic antibodies and vaccines developed against unmutated, original SARS-CoV-2 virus, delta is the most virulent leading to severe symptoms and increased mortality among infected people. A new peer-reviewed study provides answers to why delta is the most lethal variant of SARS-CoV-2.
Research Pharmacy Pharmaceutical Sciences
A new study published in today’s issue of Biochemistry is the first to explore the effects of multiple mutations in the evolution of SARS-CoV-2 variants. The findings can help scientists better understand the properties of current and new variants.
Research Pharmaceutical Sciences
The University of Colorado Anschutz Medical Campus is a leader in the field of integrating pharmacogenomics into clinical care.
In celebration of Black History Month, CU Anschutz is launching the “Get to Know” series to highlight Black excellence on campus year-round – leaders, innovators and change makers who are accomplishing the extraordinary in their fields every day. The “Get to Know” series will expand throughout the year as an inclusive platform for voices on our campus.
Neuroscience Pharmacy Clinical Research
Artin (Art) Shoukas, PhD, a Johns Hopkins University professor emeritus, would have never dreamed he’d be using marijuana every night in his retirement years. He melts the medicinal form – mostly cannabidiol (CBD) with just a touch of tetrahydrocannabinol (THC) – under his tongue before dinner.
Omicron is hitting the nation hard, pushing delta out as it infects at a higher rate of speed than any SARS-CoV-2 variant so far. In past days, infection rates in some of Colorado’s mountain towns have topped the nation, even in areas with high vaccination rates.
Her cells, nicknamed HeLa cells, changed medicine’s path. They became the most-commonly used cancer cell line in biological research history, making profound contributions to science and saving countless lives. Years after the poor Black woman unknowingly provided those cells to scientists, her story emerged, shining light on patient rights.
Research Patient Care COVID-19
Vaccines remain the best shield against COVID-19, but for those who’ve been infected with the coronavirus, the treatment arsenal continues to expand. This month, the first antiviral pill to treat COVID was submitted to the Food and Drug Administration (FDA) for emergency authorization.
For today’s generation of medical researchers, the need for speed in the scientific world was never more pronounced than it was in 2020. As society hid from a deadly virus, the race for a treatment went full-throttle, pinning some scientists in their labs nearly 24/7.
Editor's Note: This is the first in a periodic series of articles showcasing the creative talents of our faculty and students on the CU Anschutz Medical Campus. If you know of someone doing innovative work in the classroom, please send us a tip here.
Slaying creepy bugs with an arsenal of foreign firearms or being thrown into an escape room where the entire Front Range population dies if they fail are just average tasks for Meghan Jeffres’ students.
Chris Casey
